Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 19, 2021

BUY
$18.15 - $27.75 $6,425 - $9,823
354 Added 242.47%
500 $12,000
Q1 2021

Apr 26, 2021

SELL
$20.71 - $51.02 $91,124 - $224,488
-4,400 Reduced 96.79%
146 $3,000
Q4 2020

Jan 21, 2021

BUY
$21.84 - $44.0 $94,916 - $191,224
4,346 Added 2173.0%
4,546 $166,000
Q3 2020

Oct 27, 2020

SELL
$13.63 - $24.12 $10,904 - $19,296
-800 Reduced 80.0%
200 $4,000
Q4 2019

Feb 06, 2020

BUY
$8.73 - $12.95 $8,730 - $12,950
1,000 New
1,000 $10,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $225M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.